The industry of glass primary packaging is seeing a rapid shift towards the usage of plastic substitutes for specific end uses (biotech drug packaging, prefilled syringes etc). M. Abhiraj of Beroe Inc. deals with the underlying facts related to the issue of glass substitution, taking into consideration the cost of recalls and total cost of ownership, but also the impact substitution has over procurement factors such as raw material sourcing, industry integration, and manufacturing of packaging.
https://international-pharma.com/wp-content/uploads/2014/07/Parenteral.pdf